Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LENZ Therapeutics, Inc. (LENZ) Non Operating Income (2022 - 2023)

LENZ Therapeutics (LENZ) has disclosed Non Operating Income for 2 consecutive years, with $267000.0 as the latest value for Q4 2023.

  • On a quarterly basis, Non Operating Income fell 87.59% to $267000.0 in Q4 2023 year-over-year; TTM through Dec 2023 was $93000.0, a 97.01% decrease, with the full-year FY2024 number at $289000.0, up 210.75% from a year prior.
  • Non Operating Income was $267000.0 for Q4 2023 at LENZ Therapeutics, up from -$101000.0 in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $2.2 million in Q4 2022 to a low of -$101000.0 in Q3 2023.